Company Overview
2023
- “Business Leadership of the year Award-2023” awarded to Dr A.K.Sabharwal by National Achievers Recognition Forum (NARF), India.
2022
- Pharmaffiliates has been awarded again with the most prestigious award of Top 100 Best Small & Medium Enterprises, third time in a row.
- In Aug 2022, Pharmaffiliates was awarded as the 'Iconic Brand Of The Year' by Blossoms Media, Mumbai.
2021
- On 11th Dec. 2021, our Founder Director, Dr Ashok Kumar Sabharwal has been awarded the most prestigious award of “OUTSTANDING SCIENTIST AND INNOVATIVE ENTERPRENEUR” by Indian Institute of Material Management.
2019
- Transition from ISO Guide 34 (RC -1004) to ISO 17034 certification (RC -1004)
- Awarded India SME 100 Awards on 28th June 2019 at International SME Convention 2019. This award is India’s most prestigious awards for small and medium Enterprises.
2018
- Pharmaffiliates proudly enters its 18th year since its inception in strongest ever position serving the leading pharmaceutical key opinion leaders across globe.
2017
- Certified with ISO Guide 34 (RC -1004)
2016
- Expanded our R&D facility to different locations. New R&D lab established in Hyderabad (Andhra Pradesh), India.
2015
- Audited and Accepted by USFDA .
- Awarded India’s Best SMEs by Skoch group, a leading consultancy service group
2014
- Expanded the manufacturing successfully upto 22000 sq. ft.
2012
- Accredited with1SO 9001 and ISO 17025 (TC-7535)
2008
- Organization becomes an Indian MNC. Start operating from other global offices in USA, Canada, Europe and Turkey.
2007
- Officially registered and certified by Indian FDA.
2005
- Established R&D Centre in Panchkula (Haryana), India.
- Officially registered and certified by ISO 9001:2008
2001
- Established with vision as a Research Based Organization by the founder Director Dr. A.K. Sabharwal.
